Finding the perfect gift for a fitness fanatic can be as exhilarating as a high-intensity workout class. Whether you’re ...

The deal does not include a provision to raise the debt limit. After days of heated negotiations on Capitol Hill and eleventh-hour interference from President-elect Donald Trump and his ally Elon ...

Pickleball paddles have evolved fast—from basic wood designs to high-tech, performance-focused models. But with the rise of ...

A government official confirmed the approvals, saying, "The total claims from these two applicants amount to approximately Rs 246 crore, which have been examined and recommended by the Project ...

Rich Scherr is a seasoned journalist and editor who has traveled across the U.S., Canada, and Europe, and spent more than a decade reviewing hotel room.

In a statement sent to Fox News Digital, Joshua Murdock, PharmD, pharmacy editor at GoodRx, commented on the "significant number" of already-approved medications that were approved for new uses in ...

The staff alleged that she approved most of the Kenyan projects while those in the rest of the partner states were delayed. Yeda seems to have braved all these challenges and has been praised for ...

With pre-approved credit cards, the hard pull on your credit usually happens after you accept the offer, so you may still see a small effect on your score, but only after you commit to a new card ...

A Texas woman was arrested after deputies said she fatally shot her common-law husband and set his truck on fire before trying to escape in a kayak. Faith Paige Goynes, 40, of Texas, was arrested ...

GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea By India Edwards HealthDay Reporter MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...